Tianjin Huajin Pharmaceutical

Tianjin Huajin Pharmaceutical is a prominent Chinese pharmaceutical manufacturer specializing in the production of high-quality generic medications and active pharmaceutical ingredients (APIs). The company is particularly recognized for its focus on metabolic and cardiovascular health, with a strong market presence in diabetes treatments such as metformin and gliclazide. As a subsidiary of the Tianjin Pharmaceutical Group, it operates large-scale, GMP-certified manufacturing facilities in the Tianjin region. Huajin Pharmaceutical serves both the domestic Chinese market and various international territories through its robust supply chain and distribution networks. The company maintains a commitment to research and development to optimize drug delivery and formulation stability for its core product lines.